Higher dose hydroxyurea in sickle cell disease

被引：0
|
作者：
Brodwall, Kristoffer [1 ]
机构：
[1] Haukeland Univ Sjukehus, Bergen, Norway
来源：
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2020年 / 140卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1449 / 1449
页数：1
相关论文
共 50 条
  • [31] Sickle cell disease: Is hydroxyurea the final answer?
    Mohammed Ramzan
    Satya P. Yadav
    Indian Pediatrics, 2014, 51 : 156 - 156
  • [32] Length of treatment and dose as determinants of mutagenicity in sickle cell disease patients treated with hydroxyurea
    Maluf, Sharbel
    Pra, Daniel
    Friedrisch, Joao R.
    Bittar, Christina
    da Silva, Maria A. Lima
    Henriques, Joao A.
    Silla, Lucia
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2009, 27 (01) : 26 - 29
  • [33] Hydroxyurea in the sickle cell disease modern era
    Riley, Chazmyn
    Kraft, Walter K.
    Miller, Robin
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (09) : 777 - 791
  • [34] Hydroxyurea for Sickle Cell Disease: Now Is the Time!
    Strouse, John J.
    SOUTHERN MEDICAL JOURNAL, 2016, 109 (09) : 535 - 537
  • [35] Hydroxyurea in Sickle Cell Disease: Drug Review
    Agrawal, Rohit Kumar
    Patel, Rakesh Kantilal
    Shah, Varsha
    Nainiwal, Lalit
    Trivedi, Bhadra
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 (02) : 91 - 96
  • [36] Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents
    Reddy, Paavani S.
    Cai, Stephanie W.
    Barrera, Leonardo
    King, Kathryn
    Badawy, Sherif M.
    ANNALS OF MEDICINE, 2022, 54 (01) : 683 - 693
  • [37] Higher Nocturnal and Awake Oxygen Saturations in Children with Sickle Cell Disease Receiving Hydroxyurea Therapy
    Narang, Indra
    Kadmon, Gili
    Lai, Dennison
    Dhanju, Simranpal
    Kirby-Allen, Melanie
    Odame, Isaac
    Amin, Reshma
    Lu, Zihang
    Al-Saleh, Suhail
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (07) : 1044 - 1049
  • [38] Hydroxyurea and sickle cell disease: Do we need to reach the maximally tolerated dose (MTD)?
    Al-Sakkaf, W.
    Latham, T.
    Paterson, N.
    Llewellyn, O.
    Mehta, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 149 - 149
  • [39] Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease
    Houwing, Maite E.
    Bos, Jennifer
    van Wijk, Richard
    van Beers, Eduard J.
    Cnossen, Marjon H.
    Rab, Minke A. E.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (02) : 390 - 394
  • [40] LOW FIXED-DOSE HYDROXYUREA IN SEVERELY AFFECTED INDIAN CHILDREN WITH SICKLE CELL DISEASE
    Jain, Dipty L.
    Sarathi, Vijaya
    Desai, Saumil
    Bhatnagar, Manoj
    Lodha, Abhijit
    HEMOGLOBIN, 2012, 36 (04) : 323 - 332
12345